TYRX's first commercially available product is the AIGISRx Anti-Bacterial Envelope for cardiac rhythm management devices (CRMDs).

TYRX has also developed additional products to address the surgical issues of infection and inflammation. More information can be found at About Us

News & Events

Centurion & Citadel multicenter, prospective clinical trials currently enrolling

For Citadel info    For Centurion info 

TYRX, Inc. announced the commerical release of the AIGISRx™Flat

See the Data